Cell Chemical Biology

Papers
(The median citation count of Cell Chemical Biology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
30th anniversary celebrations: Inspiring innovation in biology and medicine171
Covalent targeting of splicing in T cells137
Chemoproteomic profiling of substrate specificity in gut microbiota-associated bile salt hydrolases129
Human AKR1C3 binds agonists of GPR84 and participates in an expanded polyamine pathway128
Structure-kinetic relationship reveals the mechanism of selectivity of FAK inhibitors over PYK2121
Small molecules targeting selective PCK1 and PGC-1α lysine acetylation cause anti-diabetic action through increased lactate oxidation107
Therapeutic potential of inhibiting the PI3Kγ complex for leukemia93
Chemoproteomics-enabled discovery of a covalent molecular glue degrader targeting NF-κB89
The physiological and pathological roles of RNA modifications in T cells89
Heterologous characterization of mechercharmycin A biosynthesis reveals alternative insights into post-translational modifications for RiPPs88
A direct high-throughput protein quantification strategy facilitates discovery and characterization of a celastrol-derived BRD4 degrader85
Host specific sphingomyelin is critical for replication of diverse RNA viruses75
Engineered protein-small molecule conjugates empower selective enzyme inhibition73
A genome-wide CRISPR-Cas9 screen identifies CENPJ as a host regulator of altered microtubule organization during Plasmodium liver infection67
New sheriff in town: Cyclic peptide inhibitors of a DUB module65
Antisense-mediated senseful regulation of orchestrated metabolic response60
Identification of proteomic landscape of drug-binding proteins in live cells by proximity-dependent target ID59
Multiparatopic antibodies induce targeted downregulation of programmed death-ligand 157
Next steps for targeted protein degradation55
Generation of glycan-specific nanobodies55
Shining light on reprogramming Tregs for cancer therapy55
Interrogating direct NLRP3 engagement and functional inflammasome inhibition using cellular assays54
ITK degradation to block T cell receptor signaling and overcome therapeutic resistance in T cell lymphomas54
Advances and opportunities in targeted protein degradation54
A versatile residue numbering scheme for Nav and Cav channels53
Degrading the signal amplifier: ITK as a target for targeted protein degradation51
Carolyn Bertozzi: Building new bonds between molecules, fields, and communities51
An N terminomics toolbox combining 2-pyridinecarboxaldehyde probes and click chemistry for profiling protease specificity50
A transcriptional relationship with a natural product disrupts mitochondrial biogenesis50
Voices: Challenges and opportunities in regulating the immune system48
Multi-protein complexes as drug targets48
Peptidoglycan NlpC/P60 peptidases in bacterial physiology and host interactions47
Targeted degradation of transcription factors by TRAFTACs: TRAnscription Factor TArgeting Chimeras47
Dual-pharmacophore artezomibs hijack the Plasmodium ubiquitin-proteasome system to kill malaria parasites while overcoming drug resistance46
Structural and mechanistic investigations of protein S-glycosyltransferases46
How to kill an ERKsome target: PROTACs deliver the deathblow45
Thermal proteome profiling identifies the membrane-bound purinergic receptor P2X4 as a target of the autophagy inhibitor indophagolin45
Help! I need a WNT antibody. Help! Not just any antibody44
Resistance of Mycobacterium tuberculosis to indole 4-carboxamides occurs through alterations in drug metabolism and tryptophan biosynthesis43
Meet the Authors: Christopher R. Mansfield and Emily R. Derbyshire43
Bioorthogonal dissection of the replicase assembly of hepatitis C virus40
Lipid-derived electrophiles mediate the effects of chemotherapeutic topoisomerase I poisons40
Regulation of the endocytosis and prion-chaperoning machineries by yeast E3 ubiquitin ligase Rsp5 as revealed by orthogonal ubiquitin transfer39
Targeting allostery in the Dynein motor domain with small molecule inhibitors39
HER2-targeted antibody-drug conjugate induces host immunity against cancer stem cells39
Avoid the trap: Targeting PARP1 beyond human malignancy38
ND3 Cys39 in complex I is exposed during mitochondrial respiration38
Generation of an anticoagulant aptamer that targets factor V/Va and disrupts the FVa-membrane interaction in normal and COVID-19 patient samples37
Screening compound libraries for H2O2-mediated cancer therapeutics using a peroxiredoxin-based sensor37
Inhibiting a dynamic viral protease by targeting a non-catalytic cysteine37
3D two-photon brain imaging reveals dihydroartemisinin exerts antiepileptic effects by modulating iron homeostasis37
Restoring two tumor suppressor pathways with one PAWI37
The role of SERPIN citrullination in thrombosis37
Cellular signals converge at the NOX2-SHP-2 axis to induce reductive carboxylation in cancer cells37
2′-OH as a universal handle for studying intracellular RNAs36
Advancing protein therapeutics through proximity-induced chemistry36
Synthetic gene circuit evolution: Insights and opportunities at the mid-scale35
Potent and selective binders of the E3 ubiquitin ligase ZNRF3 stimulate Wnt signaling and intestinal organoid growth35
Profiling of drug resistance in Src kinase at scale uncovers a regulatory network coupling autoinhibition and catalytic domain dynamics34
CBLs downregulation foretells T cell ubiquitination leading to autoimmunity34
A new light on PLCβ!33
Discovery and biosynthesis of non-canonical C16-terpenoids from Pseudomonas33
Identification of potent and reversible piperidine carboxamides that are species-selective orally active proteasome inhibitors to treat malaria33
FLEX: genetically encodable enzymatic fluorescence signal amplification using engineered peroxidase32
Development of a potent and selective chemical probe for the pleiotropic kinase CK232
Identification of an inhibitory pocket in falcilysin provides a new avenue for malaria drug development32
Engineering acyclovir-induced RNA nanodevices for reversible and tunable control of aptamer function32
Acute pharmacological degradation of ERK5 does not inhibit cellular immune response or proliferation31
An engineered cereblon optimized for high-throughput screening and molecular glue discovery31
Potent macrocycle inhibitors of the human SAGA deubiquitinating module30
Making the cut with protease engineering30
Substrate-dependent interaction of SPOP and RACK1 aggravates cardiac fibrosis following myocardial infarction30
Development of potent and selective inhibitors targeting the papain-like protease of SARS-CoV-229
NAPE-PLD is target of thiazide diuretics29
Motif-dependent immune co-receptor interactome profiling by photoaffinity chemical proteomics28
An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 Mpro inhibitor28
New advisory board members speak on challenges and opportunities in chemical biology28
A highly selective, cell-permeable furin inhibitor BOS-318 rescues key features of cystic fibrosis airway disease28
Photoaffinity labeling coupled with proteomics identify PDI-ADAM17 module is targeted by (−)-vinigrol to induce TNFR1 shedding and ameliorate rheumatoid arthritis in mice27
Advances in spatial proteomics: Mapping proteome architecture from protein complexes to subcellular localizations27
Genetically incorporated crosslinkers identify regulators of membrane protein PD-L1 in mammalian cells27
Endogenous anti-tumorigenic nitro-fatty acids inhibit the ubiquitin-proteasome system by directly targeting the 26S proteasome26
VIPER-TACs leverage viral E3 ligases for disease-specific targeted protein degradation26
IFNα primes cancer cells for Fusicoccin-induced cell death via 14-3-3 PPI stabilization26
Epigenetic fluidity meets phenotypic malleability in intestinal epithelial cells26
A split-luciferase lysate-based approach to identify small-molecule modulators of phosphatase subunit interactions25
Development of potent dimeric inhibitors of GAS41 YEATS domain25
Non-canonical function of histone methyltransferase G9a in the translational regulation of chronic inflammation25
HER-096 is a CDNF-derived brain-penetrating peptidomimetic that protects dopaminergic neurons in a mouse synucleinopathy model of Parkinson’s disease25
CRAGE-CRISPR facilitates rapid activation of secondary metabolite biosynthetic gene clusters in bacteria25
HATS off to KAT6A/B inhibitors: A new way to target estrogen-receptor-positive breast cancer25
The chemical tools for imaging dopamine release25
Modifying the antiviral innate immune response by selective writing, erasing, and reading of m6A on viral and cellular RNA25
Identifying and antagonizing the interactions between layilin and glycosylated collagens25
How to untie G-quadruplex knots and why?24
Exploiting ubiquitin ligase cereblon as a target for small-molecule compounds in medicine and chemical biology24
Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronaviruses24
TK216 targets microtubules in Ewing sarcoma cells24
Integrating inflammatory biomarker analysis and artificial-intelligence-enabled image-based profiling to identify drug targets for intestinal fibrosis24
Novel Frizzled-specific antibody-based Wnt mimetics and Wnt superagonists selectively activate WNT/β-catenin signaling in target tissues24
Identification of two repurposed drugs targeting GSDMD oligomerization interface I to block pyroptosis24
Control of topoisomerase II activity and chemotherapeutic inhibition by TCA cycle metabolites24
Rapamycin targets STAT3 and impacts c-Myc to suppress tumor growth23
Combined morphological and proteome profiling reveals target-independent impairment of cholesterol homeostasis23
Transient hydroxycholesterol treatment restrains TCR signaling to promote long-term immunity23
Dimerization of β2-adrenergic receptor is responsible for the constitutive activity subjected to inverse agonism23
A Pseudomonas aeruginosa PQS quorum-sensing system inhibitor with anti-staphylococcal activity sensitizes polymicrobial biofilms to tobramycin23
FADS2-dependent fatty acid desaturation dictates cellular sensitivity to ferroptosis and permissiveness for hepatitis C virus replication23
Tumor microenvironmental nutrients, cellular responses, and cancer23
A metagenomic library cloning strategy that promotes high-level expression of captured genes to enable efficient functional screening23
An E3 ligase guide to the galaxy of small-molecule-induced protein degradation23
The impact of iron and heme availability on the healthy human gut microbiome in vivo and in vitro23
Allosteric regulation of DNA binding and target residence time drive the cytotoxicity of phthalazinone-based PARP-1 inhibitors23
Visualization of calpain-1 activation during cell death and its role in GSDMD cleavage using chemical probes23
Localization matters in targeted protein degradation22
Early DNA damage detection and cellular autophagy as drivers of stress-adaptive H2S production: A paradox resolved22
The Plasmodium falciparum ABC transporter ABCI3 confers parasite strain-dependent pleiotropic antimalarial drug resistance22
Development of an intracellular quantitative assay to measure compound binding kinetics22
Targeting VPS41 induces methuosis and inhibits autophagy in cancer cells21
Meet the Authors: Harkamal S. Jhajj and Peter M. Tessier21
PALP: A rapid imaging technique for stratifying ferroptosis sensitivity in normal and tumor tissues in situ21
Inducible mismatch repair streamlines forward genetic approaches to target identification of cytotoxic small molecules21
Lockdown, a selective small-molecule inhibitor of the integrin phosphatase PPM1F, blocks cancer cell invasion21
Targeting biomolecular condensates: The rise of engineered chaperones20
Lipid availability influences ferroptosis sensitivity in cancer cells by regulating polyunsaturated fatty acid trafficking20
Anti-tumor immunotherapy using engineered bacterial outer membrane vesicles fused to lysosome-targeting chimeras mediated by transferrin receptor20
Disrupting neuron-tumor networking connections20
Sweet sensation: Developing a single-cell fluorescent reporter of glycolytic heterogeneity20
Using chemical biology for targeting cancer20
An affinity-based depletion strategy for evaluating the effects of ergothioneine on bacterial physiology20
Targeting selective E3 ligase for healing cardiac fibrosis20
Identification of small molecules that strongly inhibit bacterial quorum sensing using a high-throughput lipid vesicle lysis assay19
Serotonin is a common thread linking different classes of antidepressants19
Selective targeting of Plasmodium falciparum Hsp90 disrupts the 26S proteasome19
Chemical proteomics to study metabolism, a reductionist approach applied at the systems level19
Mechanisms by which microbiome-derived metabolites exert their impacts on neurodegeneration19
Profiling nuclear cysteine ligandability and effects on nuclear localization using proximity labeling-coupled chemoproteomics19
β-hydroxybutyrate is a metabolic regulator of proteostasis in the aged and Alzheimer disease brain19
Chemoproteomic profiling to identify activity changes and functional inhibitors of DNA-binding proteins19
Development of an intracellular quantitative assay to measure compound binding kinetics19
Investigating the NRAS 5′ UTR as a target for small molecules19
The chemistry of electrical signaling in sodium channels from bacteria and beyond18
Induced proximity labeling and editing for epigenetic research18
Integrated genomics and chemical biology herald an era of sophisticated antibacterial discovery, from defining essential genes to target elucidation18
When CDK4/6i meets GPX4i: Stop dividing to die iron hard18
Membrane remodeling via ubiquitin-mediated pathways18
Beyond antibiotic resistance: The whiB7 transcription factor coordinates an adaptive response to alanine starvation in mycobacteria18
Identification of clickable HIV-1 capsid-targeting probes for viral replication inhibition18
Break Away: FKBP12 sequestration as a target for increasing BMP activity17
A synthetic RNA-based biosensor for fructose-1,6-bisphosphate that reports glycolytic flux17
Raf protomers: Drug binding preferences in living cells17
Intracellular H2S production is an autophagy-dependent adaptive response to DNA damage17
Accelerating multiplexed profiling of protein-ligand interactions: High-throughput plate-based reactive cysteine profiling with minimal input17
Chemical control of multidomain acetyltransferase activity17
NAD reloaded: Hacking bacterial defenses17
Resolving the deceptive isoform and complex selectivity of HDAC1/2 inhibitors16
Scribble sub-cellular localization modulates recruitment of YES1 to regulate YAP1 phosphorylation16
Proteomics of broad deubiquitylase inhibition unmasks redundant enzyme function to reveal substrates and assess enzyme specificity16
Voices: Challenges and opportunities for bioorthogonal chemistry16
Periplasmic expression of SpyTagged antibody fragments enables rapid modular antibody assembly16
Increased energy demand from anabolic-catabolic processes drives β-lactam antibiotic lethality16
A sticky situation for targeted cancer therapy16
Synergistic PIM kinase and proteasome inhibition as a therapeutic strategy for MYC-overexpressing triple-negative breast cancer16
Combating the myth of “innate genius” in science16
Meet the authors: Xueqin Jin, Jian Huang, Huan Wang, Kan Wang, and Nieng Yan16
Dual targeting of DDX3 and eIF4A by the translation inhibitor rocaglamide A16
Fishing for a balance: Toward promyelinating drug discovery16
Catalytic spike antibodies: A new paradigm in neutralization16
Excited to see you: New imaging approaches to detect ferrous iron in vivo16
Light-controllable RNA-protein devices for translational regulation of synthetic mRNAs in mammalian cells16
Targeting type I DED interactions at the DED filament serves as a sensitive switch for cell fate decisions15
Targeting N-Myc in neuroblastoma with selective Aurora kinase A degraders15
Un-FASN-ing cancer’s seat belt: Linking lipid metabolism and antigen presentation15
Selective vulnerabilities in the proteostasis network of castration-resistant prostate cancer15
A complex puzzle: Regulation of SLFN12 RNase activity by phosphorylation15
Decoding retrons: Breakthroughs in RT-DNA production and genome editing15
Anaerobic purinolytic enzymes enable dietary purine clearance by engineered gut bacteria15
Metabolic targeting of cancer by a ubiquinone uncompetitive inhibitor of mitochondrial complex I15
The septin modifier, forchlorfenuron, activates NLRP3 via a potassium-independent mitochondrial axis15
TPC2 targeting evolution: Leveraging therapeutic opportunities for cancer15
CLK2 and CLK4 are regulators of DNA damage-induced NF-κB targeted by novel small molecule inhibitors15
Integration of metabolism and regulation reveals rapid adaptability to growth on non-native substrates15
Discovery of a Pseudomonas aeruginosa-specific small molecule targeting outer membrane protein OprH-LPS interaction by a multiplexed screen14
Endogenous vitamin E metabolites mediate allosteric PPARγ activation with unprecedented co-regulatory interactions14
Targeting non-canonical pathways as a strategy to modulate the sodium iodide symporter14
Tools to investigate the cell surface: Proximity as a central concept in glycoRNA biology14
Chemically modified guide RNAs enhance CRISPR-Cas13 knockdown in human cells14
A phospholipid mimetic targeting LRH-1 ameliorates colitis14
Antiplasmodial peptaibols act through membrane directed mechanisms14
Expanding the arsenal of E3 ubiquitin ligases for proximity-induced protein degradation14
Anti-tumor effect of PD-L1-targeting antagonistic aptamer-ASO delivery system with dual inhibitory function in immunotherapy14
Utilizing directed evolution to interrogate and optimize CRISPR/Cas guide RNA scaffolds14
Resident and elicited murine macrophages differ in expression of their glycomes and glycan-binding proteins14
Cell-selective bioorthogonal labeling14
A double on the Rocs with a twist: Rocaglamide A targets multiple DEAD-box helicases to inhibit translation initiation14
The role of reversible and irreversible covalent chemistry in targeted protein degradation14
Inhibitors of the ATPase p97/VCP: From basic research to clinical applications14
Tracking the PROTAC degradation pathway in living cells highlights the importance of ternary complex measurement for PROTAC optimization14
A fine-tuned azobenzene for enhanced photopharmacology in vivo14
Heterogeneity of tethered agonist signaling in adhesion G protein-coupled receptors13
Autotaxin facilitates selective LPA receptor signaling13
In-depth characterization of ubiquitin turnover in mammalian cells by fluorescence tracking13
AspSnFR: A genetically encoded biosensor for real-time monitoring of aspartate in live cells13
Discovery of YAP1/TAZ pathway inhibitors through phenotypic screening with potent anti-tumor activity via blockade of Rho-GTPase signaling13
Real-time non-invasive fluorescence imaging of gut commensal bacteria to detect dynamic changes in the microbiome of live mice13
Biogenesis and roles of tRNA queuosine modification and its glycosylated derivatives in human health and diseases13
Dissecting the neuroprotective interaction between the BH4 domain of BCL-w and the IP3 receptor13
Identification of triazenyl indoles as inhibitors of fungal fatty acid biosynthesis with broad-spectrum activity13
Ferroptosis inhibition by oleic acid mitigates iron-overload-induced injury13
Peptide-mediated inhibition of the transcriptional regulator Elongin BC induces apoptosis in cancer cells13
Target deconvolution with matrix-augmented pooling strategy reveals cell-specific drug-protein interactions13
PARP trapping is governed by the PARP inhibitor dissociation rate constant13
N6-methyladenosine modification in 18S rRNA promotes tumorigenesis and chemoresistance via HSF4b/HSP90B1/mutant p53 axis13
Fatty acid chain length drives lysophosphatidylserine-dependent immunological outputs13
A histone deacetylase network regulates epigenetic reprogramming and viral silencing in HIV-infected cells13
Genome- and metabolome-guided discovery of marine BamA inhibitors revealed a dedicated darobactin halogenase13
Identification of covalent inhibitors that disrupt M. tuberculosis growth by targeting multiple serine hydrolases involved in lipid metabolism12
Global profiling identifies a stress-responsive tyrosine site on EDC3 regulating biomolecular condensate formation12
Multiplexed bioluminescence imaging with a substrate unmixing platform12
Taming transcription factors with TRAFTACs12
Dual-action compounds unleash a one-two punch against tuberculosis12
Cell Chemical Biology announces changes to the editorial team12
Chemoproteomics-enabled discovery of covalent RNF114-based degraders that mimic natural product function12
Getting in on the action: New tools to see SARS-CoV-2 infect a cell12
Finding my leadership style12
TRIM21 is a druggable target for the treatment of metastatic colorectal cancer through ubiquitination and activation of MST212
Addressing the Enzyme-independent tumor-promoting function of NAMPT via PROTAC-mediated degradation12
Ferroptosis execution: Is it all about ACSL4?12
Glycopeptidolipid glycosylation controls surface properties and pathogenicity in Mycobacterium abscessus12
How do you mend inactive tumor suppressor mutants? You glue them!12
Proteasome inhibitors: The next generation of antimalarial drugs?12
Human nuclear hormone receptor activity contributes to malaria parasite liver stage development12
The next Nobel Prize in chemistry or in physiology or medicine12
Identification and characterization of a potent and selective HUNK inhibitor for treatment of HER2+ breast cancer12
Lenalidomide bypasses CD28 co-stimulation to reinstate PD-1 immunotherapy by activating Notch signaling12
Small molecules as tools for functional assessment of deubiquitinating enzyme function11
Proximity-labeling chemoproteomics defines the subcellular cysteinome and inflammation-responsive mitochondrial redoxome11
Pharmacological management of disease by overcoming structural adversity11
Inhibition of a lower potency target drives the anticancer activity of a clinical p38 inhibitor11
Selective and brain-penetrant lanosterol synthase inhibitors target glioma stem-like cells by inducing 24(S),25-epoxycholesterol production11
Ferroptosis inhibition by lysosome-dependent catabolism of extracellular protein11
Convergent impact of vaccination and antibiotic pressures on pneumococcal populations11
Genetic retargeting of E3 ligases to enhance CAR T cell therapy11
Inhibiting GLUTtony in cancer11
Challenges and opportunities in targeting metabolism11
A non-rational approach to optimized targeting of CRISPR-Cas9 complexes11
The interaction between NLRP1 and oxidized TRX1 involves a transient disulfide bond11
Velcrin compounds activate the SLFN12 tRNase to induce tomoptosis10
AGC kinase inhibitors regulate STING signaling through SGK-dependent and SGK-independent mechanisms10
A game of networks: Do different lipids interact to orchestrate inflammatory homeostasis?10
0.065812110900879